Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB
FDA Drug Application 021986 by BRISTOL MYERS SQUIBB
Application Number
021986
Application Type
New Drug Application
Sponsor Applicant
BRISTOL MYERS SQUIBB
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New molecular entity (NME)
Therapeutic Potential
Priority
Orphan Code
V
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
6/28/2006
N
14390
000
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021986lbl.pdf
7/3/2006
AP
0
6/28/2006
N
14405
000
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021986s000ltr.pdf
7/3/2006
AP
0
6/28/2006
N
14787
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021986_022072_SprycelTOC.cfm
9/6/2006
AP
0
11/8/2007
SE2
18450
001
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021986s001, 021986s002ltr.pdf
11/19/2007
AP
0
11/8/2007
SE2
30061
001
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021986_s001_s002.pdf
9/22/2011
AP
0
11/8/2007
SE8
18414
002
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021986s001s002lbl.pdf
11/13/2007
AP
0
11/8/2007
SE8
18449
002
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021986s001, 021986s002ltr.pdf
11/19/2007
AP
0
11/8/2007
SE8
30062
002
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021986_s001_s002.pdf
9/22/2011
AP
0
5/30/2008
SCS
19918
003
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021986s003,022072s001ltr.pdf
6/3/2008
AP
0
5/21/2009
SE2
22604
004
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021986s004lbl.pdf
5/25/2009
AP
0
5/21/2009
SE2
22653
004
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021986s004ltr.pdf
5/29/2009
AP
0
7/28/2010
SLR
26068
005
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s005lbl.pdf
7/31/2010
AP
0
7/28/2010
SLR
26122
005
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022072s002,021986s005ltr.pdf
8/9/2010
AP
0
10/28/2010
SE8
26819
007
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf
10/28/2010
AP
0
10/28/2010
SE8
26876
007
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021986s007ltr.pdf
11/3/2010
AP
0
10/28/2010
SE1
26821
008
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf
10/28/2010
AP
0
10/28/2010
SE1
26877
008
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021986s008ltr.pdf
11/3/2010
AP
0
10/7/2011
SLR
30260
009
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021986s009s010lbl.pdf
10/12/2011
AP
0
10/7/2011
SLR
30296
009
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021986s009,s010ltr.pdf
10/13/2011
AP
0
10/7/2011
SLR
30261
010
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021986s009s010lbl.pdf
10/12/2011
AP
0
10/7/2011
SLR
30297
010
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021986s009,s010ltr.pdf
10/13/2011
AP
0
6/17/2013
SLR
36295
013
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021986s013lbl.pdf
6/17/2013
AP
0
6/17/2013
SLR
36335
013
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021986Orig1s013ltr.pdf
6/18/2013
AP
0
4/10/2014
SLR
39035
014
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021986Orig1s014ltr.pdf
4/14/2014
AP
0
4/10/2014
SLR
39295
014
http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021986s014lbl.pdf
5/12/2014
AP
0
1/26/2015
SCM
AP
0
8/12/2015
SE8
43643
016
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021986s016s017lbledt.pdf
8/13/2015
AP
0
8/12/2015
SE8
43651
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021986Orig1s016,s017ltr.pdf
8/14/2015
AP
0
8/12/2015
SLR
43644
017
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021986s016s017lbledt.pdf
8/13/2015
AP
0
8/12/2015
SLR
43652
017
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021986Orig1s016,s017ltr.pdf
8/14/2015
AP
0
9/27/2016
SLR
47211
018
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021986s018lbl.pdf
9/29/2016
AP
0
9/27/2016
SLR
47240
018
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021986Orig1s018ltr.pdf
9/30/2016
Back to FDA Applications sponsored by BRISTOL MYERS SQUIBB